These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32759565)

  • 61. Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays.
    Hillarp A; Strandberg K; Baghaei F; Fagerberg Blixter I; Gustafsson KM; Lindahl TL
    Scand J Clin Lab Invest; 2018; 78(7-8):575-583. PubMed ID: 30278787
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transient lupus anticoagulant associated with prothrombin deficiency: unusual cause of bleeding in a 5-year-old girl.
    Humphries JE; Acker MN; Pinkston JE; Ruddy S
    Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):372-6. PubMed ID: 7978060
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Resolving DOAC interference on aPTT, PT, and lupus anticoagulant testing by the use of activated carbon.
    Frans G; Meeus P; Bailleul E
    J Thromb Haemost; 2019 Aug; 17(8):1354-1362. PubMed ID: 31102433
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Acquired von Willebrand's syndrome in association with a lupus-like anticoagulant corrected by intravenous immunoglobulin.
    Hanley D; Arkel YS; Lynch J; Kamiyama M
    Am J Hematol; 1994 Jun; 46(2):141-6. PubMed ID: 8172182
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Determining the cut-off value of the APTT mixing test for factor VIII inhibitor: reply.
    Kumano O; Ieko M
    Clin Chem Lab Med; 2019 Apr; 57(5):e91-e93. PubMed ID: 30822275
    [No Abstract]   [Full Text] [Related]  

  • 66. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Coagulation and bleeding disorders: review and update.
    Triplett DA
    Clin Chem; 2000 Aug; 46(8 Pt 2):1260-9. PubMed ID: 10926920
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of four coagulation tests to detect plasma lupus anticoagulants.
    Saxena R; Saraya AK; Kotte VK; Singh YN; Prasad L; Malviya AN
    Am J Clin Pathol; 1991 Dec; 96(6):755-8. PubMed ID: 1746492
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Significance of the lupus anticoagulant.
    Espinoza LR; Hartmann RC
    Am J Hematol; 1986 Jul; 22(3):331-7. PubMed ID: 3087160
    [No Abstract]   [Full Text] [Related]  

  • 70. Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor IXa/factor X bispecific antibody emicizumab.
    Nogami K; Matsumoto T; Tabuchi Y; Soeda T; Arai N; Kitazawa T; Shima M
    J Thromb Haemost; 2018 Jun; 16(6):1078-1088. PubMed ID: 29645406
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lupus anticoagulant associated with specific inhibition of factor VII in a patient with AIDS.
    Ndimbie OK; Raman BK; Saeed SM
    Am J Clin Pathol; 1989 Apr; 91(4):491-3. PubMed ID: 2494880
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Acquired factor V inhibitor associated with life-threatening bleeding and a mixing test result that indicated coagulation factor deficiency.
    Ashizawa M; Kimura S; Wada H; Sakamoto K; Sato M; Terasako K; Kikuchi M; Nakasone H; Okuda S; Kako S; Yamazaki R; Oshima K; Matsuura K; Ohmori T; Madoiwa S; Nishida J; Mimuro J; Tabei K; Sakata Y; Kanda Y
    Hematology; 2013 Sep; 18(5):300-4. PubMed ID: 23683688
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Alternative assays to dRVVT and aPTT for lupus anticoagulant detection.
    Moore GW
    Am J Hematol; 2020 Aug; 95(8):992-998. PubMed ID: 32311119
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine.
    Michiels JJ; Schroyens W; Berneman Z; van der Planken M
    Clin Appl Thromb Hemost; 2001 Apr; 7(2):113-5. PubMed ID: 11292187
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Exogenous Magnesium Chloride Reduces the Activated Partial Thromboplastin Times of Lupus Anticoagulant-Positive Patients.
    Tokutake T; Baba H; Shimada Y; Takeda W; Sato K; Hiroshima Y; Kirihara T; Shimizu I; Nakazawa H; Kobayashi H; Ishida F
    PLoS One; 2016; 11(6):e0157835. PubMed ID: 27355205
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Case report: the lupus anticoagulant-hypoprothrombinemia syndrome.
    Peacock NW; Levine SP
    Am J Med Sci; 1994 May; 307(5):346-9. PubMed ID: 8172228
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Analysis of an abnormal coagulation profile in children qualified for adenoidectomy/tonsilectomy].
    Kitszel A; Poznańska M; Krawczuk-Rybak M
    Otolaryngol Pol; 2007; 61(2):158-61. PubMed ID: 17668802
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time.
    Burns ER; Goldberg SN; Wenz B
    Am J Clin Pathol; 1993 Aug; 100(2):94-8. PubMed ID: 8356955
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Activated partial thromboplastin time derivative curves: helpful diagnostic tool in mixing test interpretation.
    Esmedere Eren S; Karakukcu C; Ciraci MZ; Ustundag Y; Karakukcu M
    Blood Coagul Fibrinolysis; 2018 Jun; 29(4):410-414. PubMed ID: 29708898
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lupus anticoagulant-hypoprothrombinemia syndrome with severe bleeding diathesis after coronavirus disease 2019: a case report.
    Brblić T; Brčić K; Margetić S; Čaržavec D; Gaćina P; Bogdanić N
    Croat Med J; 2022 Oct; 63(5):490-494. PubMed ID: 36325674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.